[Presentation of the cooperative study COALL-80 on treatment of childhood ALL (author's transl)]
Standard
[Presentation of the cooperative study COALL-80 on treatment of childhood ALL (author's transl)]. / Winkler, K; Matzke, E; Caspers, S; Erttmann, Rudolf; Grosch-Wörner, I; Kabisch, H; Müller, J; Landbeck, G.
in: KLIN PADIATR, Jahrgang 193, Nr. 3, 3, 1981, S. 155-158.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - [Presentation of the cooperative study COALL-80 on treatment of childhood ALL (author's transl)]
AU - Winkler, K
AU - Matzke, E
AU - Caspers, S
AU - Erttmann, Rudolf
AU - Grosch-Wörner, I
AU - Kabisch, H
AU - Müller, J
AU - Landbeck, G
PY - 1981
Y1 - 1981
N2 - The cooperative study COALL-80 is derived from the BFM-78-study. The aim of the study is a reduction of the initial therapy-morbidity and -mortality without loss of efficacy by omitting asparaginase from the four drug-induction regimen and interposing it between induction- and CNS-therapy phase. The expected two years disease free survival rate of a pilot study will be 82%. This finding is hitherto comparable with the BFM-study results.
AB - The cooperative study COALL-80 is derived from the BFM-78-study. The aim of the study is a reduction of the initial therapy-morbidity and -mortality without loss of efficacy by omitting asparaginase from the four drug-induction regimen and interposing it between induction- and CNS-therapy phase. The expected two years disease free survival rate of a pilot study will be 82%. This finding is hitherto comparable with the BFM-study results.
M3 - SCORING: Zeitschriftenaufsatz
VL - 193
SP - 155
EP - 158
JO - KLIN PADIATR
JF - KLIN PADIATR
SN - 0300-8630
IS - 3
M1 - 3
ER -